Evidence map›Paper›PMID 28404607›Full record

ArticleCirculation. Arrhythmia and electrophysiology2017

Interpreting Incidentally Identified Variants in Genes Associated With Catecholaminergic Polymorphic Ventricular Tachycardia in a Large Cohort of Clinical Whole-Exome Genetic Test Referrals.

Andrew P Landstrom, Andrew L Dailey-Schwartz, Jill A Rosenfeld, Yaping Yang, Margaret J McLean, Christina Y Miyake, Santiago O Valdes, Yuxin Fan, Hugh D Allen, Daniel J Penny and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation. Arrhythmia and electrophysiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. What Should a Clinical Cardiologist Know About Cardiogenetics?Journal of the American Heart Association · 2025
    Review
  4. Article
  5. Circulation. Genomic and precision medicine · 2023
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Andrew P LandstromFrom the Department of Pediatrics, Section of Pediatric Cardiology (A.P.L., A.L.D.-S., C.Y.M., S.O.V., Y.F., H.D.A., D.J.P., J.J.K.) and Cardiovascular Research Institute (A.P.L., M.J.M.), Baylor College of Medicine, Houston, TX; and Baylor Miraca Genetics Laboratories, Houston, TX (J.A.R., Y.Y.). landstro@bcm.edu jjkim@texaschildrens.org.
Andrew L Dailey-SchwartzFrom the Department of Pediatrics, Section of Pediatric Cardiology (A.P.L., A.L.D.-S., C.Y.M., S.O.V., Y.F., H.D.A., D.J.P., J.J.K.) and Cardiovascular Research Institute (A.P.L., M.J.M.), Baylor College of Medicine, Houston, TX; and Baylor Miraca Genetics Laboratories, Houston, TX (J.A.R., Y.Y.).
Jill A RosenfeldFrom the Department of Pediatrics, Section of Pediatric Cardiology (A.P.L., A.L.D.-S., C.Y.M., S.O.V., Y.F., H.D.A., D.J.P., J.J.K.) and Cardiovascular Research Institute (A.P.L., M.J.M.), Baylor College of Medicine, Houston, TX; and Baylor Miraca Genetics Laboratories, Houston, TX (J.A.R., Y.Y.).
Yaping YangFrom the Department of Pediatrics, Section of Pediatric Cardiology (A.P.L., A.L.D.-S., C.Y.M., S.O.V., Y.F., H.D.A., D.J.P., J.J.K.) and Cardiovascular Research Institute (A.P.L., M.J.M.), Baylor College of Medicine, Houston, TX; and Baylor Miraca Genetics Laboratories, Houston, TX (J.A.R., Y.Y.).
Margaret J McLeanFrom the Department of Pediatrics, Section of Pediatric Cardiology (A.P.L., A.L.D.-S., C.Y.M., S.O.V., Y.F., H.D.A., D.J.P., J.J.K.) and Cardiovascular Research Institute (A.P.L., M.J.M.), Baylor College of Medicine, Houston, TX; and Baylor Miraca Genetics Laboratories, Houston, TX (J.A.R., Y.Y.).
Christina Y MiyakeFrom the Department of Pediatrics, Section of Pediatric Cardiology (A.P.L., A.L.D.-S., C.Y.M., S.O.V., Y.F., H.D.A., D.J.P., J.J.K.) and Cardiovascular Research Institute (A.P.L., M.J.M.), Baylor College of Medicine, Houston, TX; and Baylor Miraca Genetics Laboratories, Houston, TX (J.A.R., Y.Y.).
Santiago O ValdesFrom the Department of Pediatrics, Section of Pediatric Cardiology (A.P.L., A.L.D.-S., C.Y.M., S.O.V., Y.F., H.D.A., D.J.P., J.J.K.) and Cardiovascular Research Institute (A.P.L., M.J.M.), Baylor College of Medicine, Houston, TX; and Baylor Miraca Genetics Laboratories, Houston, TX (J.A.R., Y.Y.).
Yuxin FanFrom the Department of Pediatrics, Section of Pediatric Cardiology (A.P.L., A.L.D.-S., C.Y.M., S.O.V., Y.F., H.D.A., D.J.P., J.J.K.) and Cardiovascular Research Institute (A.P.L., M.J.M.), Baylor College of Medicine, Houston, TX; and Baylor Miraca Genetics Laboratories, Houston, TX (J.A.R., Y.Y.).
Hugh D AllenFrom the Department of Pediatrics, Section of Pediatric Cardiology (A.P.L., A.L.D.-S., C.Y.M., S.O.V., Y.F., H.D.A., D.J.P., J.J.K.) and Cardiovascular Research Institute (A.P.L., M.J.M.), Baylor College of Medicine, Houston, TX; and Baylor Miraca Genetics Laboratories, Houston, TX (J.A.R., Y.Y.).
Daniel J PennyFrom the Department of Pediatrics, Section of Pediatric Cardiology (A.P.L., A.L.D.-S., C.Y.M., S.O.V., Y.F., H.D.A., D.J.P., J.J.K.) and Cardiovascular Research Institute (A.P.L., M.J.M.), Baylor College of Medicine, Houston, TX; and Baylor Miraca Genetics Laboratories, Houston, TX (J.A.R., Y.Y.).
Jeffrey J KimFrom the Department of Pediatrics, Section of Pediatric Cardiology (A.P.L., A.L.D.-S., C.Y.M., S.O.V., Y.F., H.D.A., D.J.P., J.J.K.) and Cardiovascular Research Institute (A.P.L., M.J.M.), Baylor College of Medicine, Houston, TX; and Baylor Miraca Genetics Laboratories, Houston, TX (J.A.R., Y.Y.). landstro@bcm.edu jjkim@texaschildrens.org.
Baylor College of Medicine · US

Funding

NHLBI NIH HHS L40 HL129273
6 · The paper itself

Abstract

backgroundThe rapid expansion of genetic testing has led to increased utilization of clinical whole-exome sequencing (WES). Clinicians and genetic researchers are being faced with assessing risk of disease vulnerability from incidentally identified genetic variants which is typified by variants found in genes associated with sudden death-predisposing catecholaminergic polymorphic ventricular tachycardia (CPVT). We sought to determine whether incidentally identified variants in genes associated with CPVT from WES clinical testing represent disease-associated biomarkers. METHODS AND

resultsCPVT-associated genes

conclusionsThe prevalence of incidentally identified CPVT-associated variants is ≈9% among WES tests. Variants of undetermined significances in CPVT-associated genes in WES genetic testing, in the absence of clinical suspicion for CPVT, are unlikely to represent markers of CPVT pathogenicity.

Indexed as

ExomeGenetic VariationCalsequestrinChildChild, PreschoolDatabases, GeneticDNA Mutational AnalysisFemaleGene FrequencyGenetic Association StudiesGenetic MarkersGenetic Predisposition to DiseaseGenetic TestingHeart RateHumansMaleCalsequestrinCASQ2 protein, humanGenetic MarkersRyanodine Receptor Calcium Release ChannelCasq2catecholamingeric polymorphic ventricular tachycardiaexomegeneticsgenetic testingRyR2variant of undetermined significance

Identifiers

PMID28404607
PMCPMC5391872
OpenAlexW2606266712

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.